201
Views
21
CrossRef citations to date
0
Altmetric
Case Report

The use of vasopressin in the setting of recalcitrant hypotension due to calcium channel blocker overdose

, M.D., , Pharm.D., , M.D., , F.C.C.P. , M.D., , M.D. & , Pharm.D.
Pages 56-59 | Received 24 Mar 2005, Accepted 27 Jul 2005, Published online: 07 Oct 2008

References

  • Salhanick SD, Shannon MW. Management of calcium channel antagonist Overdose. Drug Safety 2003; 26: 65–79
  • Yuan TH, Kerns WP, II, Tomaszewski CA, Ford MD, Kline JA. Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning. J Toxicol Clin Toxicol 1999; 37: 463–474
  • Ramoska EA, Spiller HA, Winter M, Borys D. A one year evaluation of calcium channel blockers overdoses: Toxicity and treatment. Ann Emerg Med 1993; 22: 196–200
  • Durward A, Guerguerian AM, Lefebvre M, et al. Massive Diltiazem overdose treated with extracorporeal membrane oxygenation. Pediatr Crit Care Med 2003; 4: 372–376
  • Lam YM, Tse HF, Lau CP. Continuous calcium chloride infusion for massive nifedipine overdose. Chest 2001; 119: 1280–1282
  • Fant JS, James LP, Fiser RT, Kearns GL. The use of glucagon in nifedipine poisoning complicated by clonidine ingestion. Pediatr Emerg Care 1997; 13: 417–419
  • Crump BJ, Holt DW, Vale JA. Lack of response to intravenous calcium in severe verapamil poisoning. Lancet 1982; 2: 939–940
  • Horowitz BZ, Rhee KJ. Massive verapamil ingestion: A report of two cases and a review of the literature. Am J Emerg Med 1989; 7: 624–631
  • Boyer EW, Shannon M. Treatment of calcium-channel-blocker intoxication with insulin infusion. N Engl J Med 2001; 344: 1721–1722
  • Watson WA, Litovitz TL, Schwartz WK, Rodgers GC, Jr, Youniss J, Reid N, Rouse WG, Rembert RS, Borys D. 2003 annual report of the American association of poison control centers toxic exposure surveillance system. Am J Emerg Med 2004; 22: 335–404
  • Dunser MW, Mayr AJ, Ulmer H, Ritsch N, Knotzer H, Pajk W, Luckner G, Mutz NJ, Hasibeder WR. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic shock and postcardiotomy shock: A retrospective analysis. Anesth Analg 2001; 93: 7–13
  • Tsuneyoshi I, Yamada H, Kakihana Y, Nakamura M, Nakano Y, Boyle WA. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 2001; 29: 487–493
  • Grassi G, Seravalle G, Turri C. Short-versus long-term effects of different dihydropyridines on sympathetic and baroreflex function in hypertension. Hypertension 2003; 41: 558–562
  • Bartelstone HJ, Nasmyth PA. Vasopressin Potentiation of catecholamine actions in dog, rat, cat and rat aortic strip. Am J Physiol 1965; 208: 754–762
  • Dunser MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W, Friesenecker B, Hasibeder WR. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 2003; 107: 2313–2319
  • Fujisawa S, Ilijima T. On the inotropic actions of arginine vasopressin in ventricular muscle of the guinea pig heart. Jpn J Pharmacol 1999; 81: 309–312
  • Okamura T, Ayajiki K, Fujioka H, Toda N. Mechanisms underlying arginine vasopressin induced relaxation in monkey isolated coronary arteries. J Hypertens 1999; 17: 673–678
  • Heyndrickx GR, Boettcher DH, Vatner SF. Effects of angiotensin, vasopressin, and methoxamine on cardiac function and blood flow distribution in conscious dogs. Am J Physiol 1976; 231: 1579–1587
  • Wenzel V, Krismer AC, Arntz HR, Sitter H, Stadlbauer KH, Lindner KH. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med 2004; 350: 105–113
  • Morales DL, Garrido MJ, Madigan JD, Helman DN, Faber J, Williams MR, Landry DW, Oz MC. A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass. Ann Thorac Surg 2003; 75: 926–930
  • Gold J, Cullinane S, Chen J, Seo S, Oz MC, Oliver JA, Landry DW. Vasopressin in the treatment of milrinone-induced hypotension in severe heart failure. Am J Cardiol 2000; 85: 506–508
  • Holstege CP, Hunter Y, Baer AB, Savory J, Bruns DE, Boyd JC. Massive caffeine overdose requiring vasopressin infusion and hemodialysis. J Toxicol Clin Toxicol 2003; 41: 1003–1007
  • Barry JD, Durkovitch DW, Richardson WH, Tony TC, Cantrell FL, Offerman SR, Clark RF, Tanem DA, Williams SR. Vasopressin treatment of verapamil toxicity in the porcine model (Abstract only). J Toxicol Clin Toxicol 2003; 41. 694
  • Sztajnkrycer MD, Bond GR, Johnson SB, Weaver AL. Use of vasopressin in a canine model of severe verapamil poisoning: a preliminary descriptive study. Acad Emerg Med 2004; 11: 1253–1261
  • Dunser MW, Wenzel V, Mayr AJ, Hasibeder WR. Management of vasodilatory shock: defining the role of arginine vasopressin. Drugs 2003; 63: 237–256

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.